BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,423,215 | -7.0% | 1,786,518 | +12.3% | 0.08% | -2.4% |
| Q2 2023 | $72,462,584 | -6.1% | 1,590,487 | -16.4% | 0.08% | -7.9% |
| Q1 2023 | $77,132,171 | -6.4% | 1,901,681 | +17.7% | 0.09% | -9.2% |
| Q4 2022 | $82,372,366 | +15.7% | 1,616,081 | +22.3% | 0.10% | +6.5% |
| Q3 2022 | $71,171,000 | -4.0% | 1,321,406 | +14.4% | 0.09% | 0.0% |
| Q2 2022 | $74,162,000 | +2.8% | 1,154,623 | +24.1% | 0.09% | +24.3% |
| Q1 2022 | $72,117,000 | -0.5% | 930,064 | +10.1% | 0.07% | +4.2% |
| Q4 2021 | $72,506,000 | -7.2% | 844,671 | -13.0% | 0.07% | -15.5% |
| Q3 2021 | $78,127,000 | -8.4% | 971,366 | -8.3% | 0.08% | -8.7% |
| Q2 2021 | $85,259,000 | +754.9% | 1,058,971 | +799.3% | 0.09% | +666.7% |
| Q1 2021 | $9,973,000 | +145.0% | 117,751 | +132.1% | 0.01% | +140.0% |
| Q4 2020 | $4,070,000 | +59.0% | 50,726 | +59.4% | 0.01% | +25.0% |
| Q3 2020 | $2,559,000 | -90.6% | 31,826 | -90.0% | 0.00% | -91.5% |
| Q2 2020 | $27,345,000 | +54.2% | 317,600 | +45.4% | 0.05% | +17.5% |
| Q1 2020 | $17,738,000 | -77.6% | 218,474 | -77.0% | 0.04% | -70.4% |
| Q4 2019 | $79,291,000 | +5.8% | 948,226 | +10.7% | 0.14% | -4.3% |
| Q3 2019 | $74,912,000 | -2.9% | 856,428 | -9.1% | 0.14% | -2.8% |
| Q2 2019 | $77,151,000 | +365.0% | 942,013 | +361.6% | 0.14% | +339.4% |
| Q1 2019 | $16,593,000 | +82.2% | 204,066 | +47.5% | 0.03% | +50.0% |
| Q4 2018 | $9,109,000 | -57.1% | 138,385 | -49.7% | 0.02% | -45.0% |
| Q3 2018 | $21,225,000 | +152.9% | 275,323 | +142.2% | 0.04% | +135.3% |
| Q2 2018 | $8,393,000 | -30.0% | 113,666 | -38.4% | 0.02% | -39.3% |
| Q1 2018 | $11,998,000 | +9.6% | 184,476 | +8.9% | 0.03% | +7.7% |
| Q4 2017 | $10,950,000 | -73.6% | 169,401 | -74.4% | 0.03% | -75.7% |
| Q3 2017 | $41,532,000 | -23.9% | 661,859 | -26.6% | 0.11% | -26.7% |
| Q2 2017 | $54,571,000 | +11.1% | 901,409 | -4.8% | 0.15% | +7.4% |
| Q1 2017 | $49,113,000 | +27.4% | 947,025 | +9.0% | 0.14% | +18.3% |
| Q4 2016 | $38,537,000 | -16.3% | 869,132 | -10.1% | 0.12% | -16.1% |
| Q3 2016 | $46,037,000 | +199.5% | 967,167 | +184.5% | 0.14% | +185.4% |
| Q2 2016 | $15,372,000 | -85.7% | 339,939 | -88.0% | 0.05% | -82.9% |
| Q4 2015 | $107,727,000 | +997.4% | 2,823,783 | +844.9% | 0.28% | +900.0% |
| Q3 2015 | $9,817,000 | -28.0% | 298,847 | +53.2% | 0.03% | -20.0% |
| Q2 2015 | $13,640,000 | +50.5% | 195,050 | +47.4% | 0.04% | +29.6% |
| Q1 2015 | $9,065,000 | -71.8% | 132,334 | -69.8% | 0.03% | -75.0% |
| Q4 2014 | $32,148,000 | +207.8% | 438,644 | +201.4% | 0.11% | +163.4% |
| Q3 2014 | $10,443,000 | -33.7% | 145,512 | -33.2% | 0.04% | -36.9% |
| Q2 2014 | $15,746,000 | +34.5% | 217,784 | +36.9% | 0.06% | +27.5% |
| Q1 2014 | $11,708,000 | +82.5% | 159,120 | +72.6% | 0.05% | +64.5% |
| Q4 2013 | $6,414,000 | +18.6% | 92,215 | +12.0% | 0.03% | +6.9% |
| Q3 2013 | $5,410,000 | -45.5% | 82,364 | -42.5% | 0.03% | -55.4% |
| Q2 2013 | $9,928,000 | – | 143,328 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |